UNLIMITED TURBO LONG - TANDEM DIABETES CARE Share Price

Certificat

DE000PG3AAK7

Market Closed - Börse Stuttgart 01:12:46 06/07/2024 am IST
1.6 EUR 0.00% Intraday chart for UNLIMITED TURBO LONG - TANDEM DIABETES CARE
Current month+4.58%
Date Price Change
05/24/05 1.6 0.00%
04/24/04 1.6 +4.58%
03/24/03 1.53 +4.08%
02/24/02 1.47 -3.92%
01/24/01 1.53 0.00%

Delayed Quote Börse Stuttgart

Last update July 06, 2024 at 01:12 am IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PG3AAK
ISINDE000PG3AAK7
Date issued 26/06/2024
Strike 25.06 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.5
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.74
Lowest since issue 1.44

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.42 USD
Average target price
49.93 USD
Spread / Average Target
+23.54%
Consensus